Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages


This content is available also in other languages

July 18, 2023 | Customer News

Tecan collaborates with NGS specialists to address critical needs in genomics research.

Maennedorf, Switzerland, July 12th, 2023 – Tecan today announced the availability of the first in a series of specialist reagent kits for its MagicPrep™ NGS library preparation system. The first kits are tailor-made for the Singular Genomics’ G4™ Sequencing Platform.

In the field of genomics, research labs face significant pressure when it comes to the demanding and time-consuming task of manually preparing NGS (next-generation sequencing) samples, a critical technique in the burgeoning fields of personalized medicine, diagnostics and clinical research.

The challenge is further intensified by a shortage of skilled personnel – a common issue in many labs. Despite these difficulties, there is an urgent need to accelerate research in critical areas such as oncology and neurodegenerative diseases, where breakthroughs can have a life-changing impact.

By combining the MagicPrep NGS system's automated library preparation with the robust sequencing performance of the G4 Sequencing Platform, researchers can achieve accelerated turnaround times, increased flexibility and outstanding data accuracy. By reducing hands-on time and avoiding library conversion steps, researchers are free to focus on core activities and scientific breakthroughs. This solution is ideal for multiple genomics applications. 

"We are thrilled to introduce our new G4-tailored kits for the MagicPrep NGS system, empowering researchers to unlock the full potential of the Singular Genomics G4 Sequencing Platform," said Luca Valeggia, Senior Vice President of Lab Automation at Tecan. “By combining Tecan's MagicPrep NGS for simple, automated library preparation and the Singular Genomics’ G4 sequencing platform for fast, high-quality sequencing, we offer a powerful solution that minimizes hands-on time and accelerates research to improve human health.”

“These new kits combine the unmatched speed and flexibility of the G4 Sequencing Platform with the simplicity and ease-of-use of MagicPrep NGS automation,” said Jorge Velarde, Senior Vice President of Corporate Development and Strategy at Singular Genomics. “We are providing customers with a solution that will streamline lab operations, reduce turnaround times and accelerate their research.”
The collaboration between Tecan and Singular Genomics is the first in a series of partnerships for the development of customized reagents for MagicPrep NGS. Tailor-made kits for specific NGS platforms will further streamline workflows and drive efficiencies in genomics research. 

The new MagicPrep NGS kits for the G4 Sequencing Platform are now available for order. To learn more, please visit https://lifesciences.tecan.com/magicprep-ngs.

About Tecan

Tecan (www.tecan.com) improves people’s lives and health by empowering customers to scale healthcare innovation globally from life science to the clinic. Tecan is a pioneer and global leader in laboratory automation. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments, components and medical devices that are then distributed by partner companies. Founded in Switzerland in 1980, the company has almost 3,500 employees, with manufacturing, research and development sites in Europe, North America and Asia, and maintains a sales and service network in over 70 countries. In 2022, Tecan generated sales of CHF 1,144 million (USD 1,192 million; EUR 1,144 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).


About Singular Genomics Systems, Inc.

Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In development, the PX system leverages Singular’s proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. With these products, Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine. Visit www.singulargenomics.com for more information.


Tecan Media Contact

Ashesh Saraiya
Associate Director of Product Management
Tel. +1-650-313 5464


Singular Genomics Media Contact

Dan Budwick, 1AB
Tel. +1-973-271-6085